To engage in scientific discovery across the cancer control continuum (e.g., primary prevention to survivorship) that translates into empirically-based interventions, clinical and public health practice, and policy strategies to reduce the cancer burden in New Jersey and beyond.
- To understand determinants of cancer risk, treatment, and survival and quality of life outcomes through epidemiological investigations with an emphasis on minorities and underserved populations. Research in this aim focuses on epidemiological studies that evaluate multi-level risk factors (e.g., environment, neighborhood, heath care system, and behavioral risk factors as well as biomarkers and molecular tumor characteristics) that contribute to disparities in cancer risk, treatment, quality of life, and survival.
- To reduce cancer risk behaviors and improve cancer outcomes through individual, family, and system-level interventions. This aim includes interventional and observational research.
- To understand tobacco use and implement effective tobacco control strategies at the individual, system, and population level to reduce tobacco-caused morbidity and mortality.
Collaborating Research Programs:
- Cancer Metabolism and Immunology
- Genomic Instability and Cancer Genetics
- Cancer Pharmacology
- Clinical Investigations and Precision Therapeutics
- CALENDAR: Program Meetings, Lectures and other events for Research Members
- List of Program Members
- Cancer Prevention and Control Selected Program-Related Publications
- Rutgers School of Public Health, Department of Health Behavior, Society and Policy (HBSP)
- Rutgers School of Public Health, Center for Tobacco Studies (CTS)
- Rutgers School of Public Health Department of Biostatistics and Epidemiology
- Screen NJ
- State of NJ Department of Health – Cancer Epidemiology Services (CES)(State Cancer Registry)